Research Study

PRidopidine's Outcome On Function in Huntington Disease (PROOF- HD)
Principal Investigator 
Blair Leavitt

Overview

Body Locations and Systems 
Huntington's Disease
ClinicalTrials.gov# 
NCT04556656
Status 
Recruiting
Study Start/End 
Mar 8, 2021
Locations 
UBC Hospital
Name/Title 
Mike Adurogbangba, Research Coordinator
Phone 
604-822-4872
Purpose of Study 

The purpose of this study is to evaluate the efficacy and safety of the drug pridopidine in patients with early stage manifest Huntington Disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.